Search alternatives:
point decrease » point increase (Expand Search)
web decrease » we decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
22 point » 29 points (Expand Search), _ point (Expand Search), 5 point (Expand Search)
point decrease » point increase (Expand Search)
web decrease » we decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
22 point » 29 points (Expand Search), _ point (Expand Search), 5 point (Expand Search)
-
1
-
2
-
3
-
4
Top Genes with Significantly Decreased Transcript Levels at the Site of SSTI<sup>1</sup>.
Published 2015“…</p><p>Top Genes with Significantly Decreased Transcript Levels at the Site of SSTI<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0124877#t003fn001" target="_blank"><sup>1</sup></a>.…”
-
5
-
6
-
7
-
8
Loss of C9orf72 decreases mTOR activation.
Published 2016“…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”
-
9
-
10
-
11
-
12
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…<p>(A) RFF is decreased by alterations in heart rate. …”
-
13
Decreased macrophage recruitment correlates with decreased angiogenesis.
Published 2013“…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”
-
14
-
15
-
16
-
17
-
18
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
19
-
20